Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...

Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well ...

Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects approximately 112 per 100,000 adults worldwide. It ...

Bristol-Myers Squibb (NYSE:BMY) on Saturday announced results from a late-stage trial for its psoriasis therapy Sotyktu in ...

The following is a summary of “Health-related quality of life significantly improved in obese patients with psoriatic arthritis one year after a structured weight loss intervention,” published in the ...

Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related ...

Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in ...

More than half of patients with fingernail psoriasis achieved complete fingernail clearance after 68 weeks of guselkumab treatment.

The following is a summary of “Potentially Avoidable Emergency Department Utilization by Persons With Psoriatic Arthritis and ...

Noting that the ultimate goal of PsA treatment is prompt reduction of disease activity, Nilasha Ghosh, MD, MS, assistant professor of medicine at Weill Cornell Medical College, also emphasizes ...

STOCKHOLM , March 13, 2025 /PRNewswire/ -- The IFPA Forum 2025 will unite stakeholders from across the Americas to address ...

STOCKHOLM , March 13, 2025 /PRNewswire/ -- The IFPA Forum 2025 will unite stakeholders from across the Americas to address the urgent challenges faced by individuals living with psoriatic ...